NCT06180980View on ClinicalTrials.gov

A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

January 4, 2021

Primary Completion Date

March 8, 2021

Study Completion Date

March 8, 2021

Conditions

Healthy

Interventions

DRUG

Pirtobrutinib

Administered orally.

Trial Locations (1)

32117

Covance Clinical Research Unit, Daytona Beach

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT06180980 - A Study of the Effect of Food on Pirtobrutinib (LOXO-305) in Healthy Participants | Biotech Hunter | Biotech Hunter